BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26385505)

  • 41. Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting.
    Kassaian SE; Goodarzynejad H; Boroumand MA; Salarifar M; Masoudkabir F; Mohajeri-Tehrani MR; Pourhoseini H; Sadeghian S; Ramezanpour N; Alidoosti M; Hakki E; Saadat S; Nematipour E
    Cardiovasc Diabetol; 2012 Jul; 11():82. PubMed ID: 22805289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated serum YKL-40 level predicts myocardial reperfusion and in-hospital MACE in patients with STEMI.
    Cetin M; Kocaman SA; Canga A; Kırbaş A; Yılmaz A; Erdoğan T; Akgül O; Uğurlu Y; Durakoğlugil ME
    Herz; 2013 Mar; 38(2):202-9. PubMed ID: 22955689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the Effects of Ticagrelor and Clopidogrel on Inflammatory Factors, Vascular Endothelium Functions and Short-Term Prognosis in Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention: a Pilot Study.
    Gao CZ; Ma QQ; Wu J; Liu R; Wang F; Bai J; Yang XJ; Fu Q; Wei P
    Cell Physiol Biochem; 2018; 48(1):385-396. PubMed ID: 30016801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention.
    Timmer JR; Hoekstra M; Nijsten MW; van der Horst IC; Ottervanger JP; Slingerland RJ; Dambrink JH; Bilo HJ; Zijlstra F; van 't Hof AW
    Circulation; 2011 Aug; 124(6):704-11. PubMed ID: 21768543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The value of admission HbA(1c) level in diabetic patients with acute coronary syndrome.
    Chan CY; Li R; Chan JY; Zhang Q; Chan CP; Dong M; Yan BP; Lam YY; Yu CM
    Clin Cardiol; 2011 Aug; 34(8):507-12. PubMed ID: 21717470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of prolonged hospital stay and in-hospital mortality in female patients with acute myocardial infarction with specific reference to diabetes.
    Shalaby G; Sabri S; Alsilami ANS; Alhassani RY; Alsayed SH; Alhazmi MAW; Aoudallah MT; Khaled S
    Int J Cardiol; 2024 Apr; 400():131785. PubMed ID: 38242505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum VCAM-1 and ICAM-1 measurement assists for MACE risk estimation in ST-segment elevation myocardial infarction patients.
    Yu J; Liu Y; Peng W; Xu Z
    J Clin Lab Anal; 2022 Oct; 36(10):e24685. PubMed ID: 36045604
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Missed Opportunities for Screening and Management of Dysglycemia among Patients Presenting with Acute Myocardial Infarction in North India: The Prospective NORIN STEMI Registry.
    Ostrominski JW; Vaduganathan M; Girish MP; Gupta P; Hendrickson MJ; Qamar A; Arora S; Pandey A; Bansal A; Batra V; Mahajan B; Mukhopadhyay S; Yusuf J; Tyagi S; Bhatt DL; Gupta MD;
    Glob Heart; 2022; 17(1):54. PubMed ID: 36051328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention.
    Liu XJ; Wan ZF; Zhao N; Zhang YP; Mi L; Wang XH; Zhou D; Wu Y; Yuan ZY
    Cardiovasc Diabetol; 2015 Aug; 14():110. PubMed ID: 26285575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-18 levels on admission are associated with mid-term adverse clinical events in patients with ST-segment elevation acute myocardial infarction undergoing percutaneous coronary intervention.
    Gao Y; Tong GX; Zhang XW; Leng JH; Jin JF; Wang NF; Yang JM
    Int Heart J; 2010 Mar; 51(2):75-81. PubMed ID: 20379038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Total occlusion of the infarct-related coronary artery correlates with brachial artery flow-mediated dilation in patients with ST-elevation myocardial infarction.
    Vasilieva E; Urazovskaya I; Skrypnik D; Shpektor A
    Acute Card Care; 2009; 11(3):155-9. PubMed ID: 19199114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Impact of type 2 diabetes mellitus on the progression and revascularization of coronary non-target lesions in patients with coronary heart disease].
    Wang J; Xu HB; Zhang HP; Chen JL; Qiao SB; Hu FH; Yang WX; Yuan JS; Liu R; Cui JG; Guo C; Duan X; Gao LJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 May; 48(5):393-400. PubMed ID: 32450656
    [No Abstract]   [Full Text] [Related]  

  • 53. Glycated hemoglobin variability and the risk of cardiovascular events in patients with prediabetes and type 2 diabetes mellitus: A post-hoc analysis of a prospective and multicenter study.
    Manosroi W; Phimphilai M; Waisayanand N; Buranapin S; Deerochanawong C; Gunaparn S; Phrommintikul A; Wongcharoen W;
    J Diabetes Investig; 2023 Dec; 14(12):1391-1400. PubMed ID: 37610280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-O blood groups can be a prognostic marker of in-hospital and long-term major adverse cardiovascular events in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Cetin MS; Ozcan Cetin EH; Aras D; Topaloglu S; Temizhan A; Kisacik HL; Aydogdu S
    Thromb Res; 2015 Sep; 136(3):599-605. PubMed ID: 26251078
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epicardial adipose tissue volume predicts long term major adverse cardiovascular events in patients with Type 2 diabetes.
    Uygur B; Çelik Ö; Demir AR; Karakayalı M; Arslan Ç; Otcu Temur H; Alis D; Yıldırım C; Çörekçioğlu B; Ertürk M
    Turk Kardiyol Dern Ars; 2021 Mar; 49(2):127-134. PubMed ID: 33709918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The significance of admission hs-CRP in patients undergoing primary percutaneous intervention for acute myocardial infarction].
    Cağli KE; Topaloğlu S; Aras D; Günel EN; Ozlü MF; Uygur B; Baysal E; Sen N
    Turk Kardiyol Dern Ars; 2009 Jan; 37(1):19-25. PubMed ID: 19225249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of glucose metabolism for non-ST-segment elevation infarction patients with diabetes mellitus and single concomitant chronic total occlusion following primary percutaneous coronary intervention.
    Xing Z; Zhang L; Liu Z; He P; Yang Y; Wulasihan M
    Medicine (Baltimore); 2017 Nov; 96(45):e8362. PubMed ID: 29137017
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating Endothelial Cells and Endothelial Function Predict Major Adverse Cardiac Events and Early Adverse Left Ventricular Remodeling in Patients With ST-Segment Elevation Myocardial Infarction.
    Abdel Hamid M; Bakhoum SW; Sharaf Y; Sabry D; El-Gengehe AT; Abdel-Latif A
    J Interv Cardiol; 2016 Feb; 29(1):89-98. PubMed ID: 26864952
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prediabetes and short-term outcomes in nondiabetic patients after acute ST-elevation myocardial infarction.
    Tian L; Zhu J; Liu L; Liang Y; Li J; Yang Y
    Cardiology; 2014; 127(1):55-61. PubMed ID: 24247598
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination of eosinophil percentage and high-sensitivity C-reactive protein predicts in-hospital major adverse cardiac events in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
    Ye L; Bai HM; Jiang D; He B; Wen XS; Ge P; Zhang DY
    J Clin Lab Anal; 2020 Sep; 34(9):e23367. PubMed ID: 32441412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.